Genetic studies have shown that a person’s DNA can hint at their chance of developing cancer. Scientists now mix this genetic signal with information about a person’s environment and habits to create a single score that predicts risk. The idea is that both inherited genes and everyday exposures—like
In Uganda, cervical cancer is the leading cancer affecting women, yet many cases are caught too late. A recent study looked at why women and health workers either do or don’t get screened. The main test used in most clinics is Visual Inspection with Acetic acid, or VIA. It’s simple and cheap, but n
Doctors often focus on the medical side of chemotherapy but forget about how patients feel deep down. For breast cancer patients, the emotional and spiritual challenges can be just as tough as the physical ones. New research highlights how important it is to address these needs, yet they usually sli
Researchers tracked how often a drug called bevacizumab improved survival without causing new lung damage in people fighting the most common type of lung cancer that starts outside the lungs. The study looked at adults who had never been treated for this cancer but were about to start a standard fir
Aumolertinib, a newer drug that targets the epidermal growth factor receptor (EGFR), has been tested in two hospitals on patients with a rare form of lung cancer. The cancer cells carry uncommon deletions in exon 19 of the EGFR gene, a pattern that often makes standard treatments less reliable. R
Medicare might soon pay for cancer screenings that arrive too late to actually help. The program currently focuses on tests that can only spot cancer after it appears, rather than finding the warning signs before illness develops. Research shows that finding and removing those early warning signs co
Men and women don’t always fight urologic cancers the same way. Studies show men face higher chances of getting these cancers and worse outcomes when they do. Why? It’s not just about behavior or habits—deep biological factors play a big role. Hormones like testosterone and estrogen don’t just affe
Doctors in the U. S. now have another tool to fight a tough cancer. The FDA gave the green light for early use of an experimental pill called daraxonrasib. It targets pancreatic ductal adenocarcinoma, a fast-spreading form of pancreatic cancer that has already resisted other treatments. Patients who
Cancer studies rely on people joining big research groups called cohorts. These groups help scientists spot patterns between lifestyle choices, genes, and cancer risks. But it takes more than just collecting data. Real progress happens when researchers treat participants like partners, not just subj
A well-known TV presenter recently shared some personal news that caught many people off guard. She revealed she has breast cancer and will pause her popular home-tour show to focus on surgery and recovery. Speaking openly on her morning show, she admitted to feeling afraid—not something most would
